Recent Lessons

Show all results for ""

Monitoring Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease

Choose a study mode

Play Quiz

Study Flashcards

Spaced Repetition

Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is a reasonable approach to monitoring patients with RA-ILD according to the text?

Request pulmonary function tests only when there is worsening of symptoms
Query about new or progressive respiratory symptoms at every clinic visit (correct)
Measure FVC and DLCO every 12 months
Perform HRCT yearly and follow-up HRCT may be useful in detecting progression of ILD

How often should FVC and DLCO be measured in patients with RA-ILD based on the text?

Every 3 to 6 months (correct)
Only when there is worsening of symptoms
Every 12 months
Every 2 years

What can follow-up HRCT help detect in patients with RA-ILD according to the text?

Muscle atrophy due to inactivity
Digestive complications related to RA medications
Progression of RA joint symptoms
Progression of ILD and evaluation for complications like pulmonary hypertension (correct)

Why is effective communication important with patients with RA-ILD?

To improve patient satisfaction and enable them to be active partners in treatment decisions (D) Signup and view all the answers

What is a common misconception about pulmonary rehabilitation for RA-ILD patients?

It has no impact on comorbidity and mortality rates (C) Signup and view all the answers

What is a key aspect of supportive care for RA-ILD patients?

Regular monitoring and management of disease progression (B) Signup and view all the answers

How should treatment response versus treatment failure be defined in patients with PPF associated with RA-ILD?

Decrease in FVC % predicted vs. stable FVC % predicted (C) Signup and view all the answers

When should patients with PPF associated with RA-ILD be evaluated for lung transplant?

Once pulmonary function tests show severe impairment (A) Signup and view all the answers

How should dyspnea and cough in patients with RA-ILD be managed?

Administering oxygen therapy (A) Signup and view all the answers

Which patients with PPF associated with RA-ILD should receive antifibrotic therapy?

Patients with PPF who have a decline in DLCO (A) Signup and view all the answers

Flashcards are hidden until you start studying